Loss of heterozygosity on chromosome 22 in human gliomas does not inactivate the neurofibromatosis type 2 gene
- 1 November 1996
- journal article
- Published by Elsevier in Cancer Genetics and Cytogenetics
- Vol. 92 (1) , 73-78
- https://doi.org/10.1016/s0165-4608(96)00149-5
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- A tiger behind many doors: multiple genetic pathways to malignant gliomaTrends in Genetics, 1995
- MTS1/CDKN2 gene mutations are rare in primary human astrocytomas with allelic loss of chromosome 9pHuman Molecular Genetics, 1994
- Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2Nature, 1993
- A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressorCell, 1993
- A genetic study of type 2 neurofibromatosis in the United Kingdom. I. Prevalence, mutation rate, fitness, and confirmation of maternal transmission effect on severity.Journal of Medical Genetics, 1992
- Loss of heterozygosity for distal markers on 22q in human gliomasInternational Journal of Cancer, 1992
- Germ Line p53 Mutations in a Familial Syndrome of Breast Cancer, Sarcomas, and Other NeoplasmsScience, 1990
- A cytogenetic study of 53 human gliomasCancer Genetics and Cytogenetics, 1989
- Chromosomal composition of a series of 22 human low-grade gliomasCancer Genetics and Cytogenetics, 1987
- Chromosomal patterns in human malignant astrocytomasCancer Genetics and Cytogenetics, 1987